Mr. Shipp joined Dow Chemical in 1981 and has held a number of leadership positions, including vice president and site director of Dow’s Louisiana operations and global operations director of the propylene oxide and glycols business. In his current role, Mr. Shipp oversees nine manufacturing sites.
“Mr. Shipp’s decades of leadership experience will add a valuable perspective to our Board,” said Michael H. Covert, CEO of CHI St. Luke’s Health in a statement. “His business acumen will be instrumental as we implement our strategic plan to advance the vision of our health system and build healthier communities throughout Southeast Texas.”
CHI St. Luke’s Health includes the Texas Heart Institute, eight hospitals, eight emergency centers, a Diagnostic & Treatment Center, a Radiation & CyberKnife Center and several locations for the St. Luke’s Medical Group.
More articles on executive moves:
9 latest hospital, health system CEO moves
After only 90 days, Plantation General Hospital CEO Robert Lee departs
Matt Schaefer to serve as Texas Children’s Hospital West Campus’ new president: 3 notes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
